Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VTV THERAPEUTICS INC.

(VTVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

vTv Therapeutics : Health Care

09/24/2021 | 08:56am EST


ę MT Newswires 2021
All news about VTV THERAPEUTICS INC.
11/09VTv Therapeutics Announces 2021 Third Quarter Financial Results and Provides Corporate ..
PU
11/09VTV THERAPEUTICS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
11/09VTV THERAPEUTICS : Q3 Earnings Snapshot
AQ
11/09VTv Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months En..
CI
11/09Earnings Flash (VTVT) VTV THERAPEUTICS Posts Q3 Revenue $3M
MT
11/09VTv Therapeutics Announces 2021 Third Quarter Financial Results and Provides Corporate ..
AQ
10/20VTV THERAPEUTICS : Names Deepa Prasad CEO, President
MT
10/20VTV THERAPEUTICS : Announces Deepa Prasad as New President and CEO - Form 8-K
PU
10/20VTV THERAPEUTICS INC. : Change in Directors or Principal Officers, Financial Statements an..
AQ
10/20VTV THERAPEUTICS : Announces Deepa Prasad as New President and CEO
PR
More news
Financials (USD)
Sales 2021 4,50 M - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 86,4 M 86,4 M -
Capi. / Sales 2021 19,2x
Capi. / Sales 2022 86,4x
Nbr of Employees 25
Free-Float 33,6%
Chart VTV THERAPEUTICS INC.
Duration : Period :
vTv Therapeutics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VTV THERAPEUTICS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,29 $
Average target price 6,75 $
Spread / Average Target 423%
Managers and Directors
Deepa Prasad President, Chief Executive Officer & Director
Rudy C. Howard EVP, Chief Financial & Accounting Officer
Robin E. Abrams Executive Chairman
Aaron H. Burstein Senior Vice President-Clinical Development
Carmen Valcarce Chief Scientific Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
VTV THERAPEUTICS INC.-30.65%86
GILEAD SCIENCES, INC.21.27%88 622
BIONTECH SE344.70%87 556
REGENERON PHARMACEUTICALS35.46%68 421
WUXI APPTEC CO., LTD.27.38%66 062
VERTEX PHARMACEUTICALS-19.56%48 336